ERBB2 and breast carcinoma: In the past 2 decades, 4 molecular classifications of breast cancer have been extensively studied (Luminal A, Luminal B, HER2-type and Triple negative breast cancer (TNBC)) that have resulted in improved treatments [5, 6].